Home > PJ > News / Daily News

Return to PJ Online Home Page

The Pharmaceutical Journal Vol 267 No 7164 p313-316
8 September 2001

This article
Reprint
Photocopy


News summary


MMR and DTP vaccines can cause febrile seizures

Children who have been given diphtheria, tetanus and pertussis (DTP) or measles, mumps and rubella (MMR) vaccines are at increased risk of suffering febrile seizures but are unlikely to suffer long-term neurological damage as a result.

This reassurance comes from a study conducted by Dr William Barlow from the Immunisation Studies Programme, University of Washington, Seattle, and colleagues.

Using children registered with the Vaccine Safety Datalink project, they looked for an association between administration of the vaccines, febrile seizures and long-term neurological disabilities. They found significantly increased risks of febrile seizures on the day of administration of DTP vaccine and eight to 14 days after MMR vaccine was given.

“This risk translates into approximately six to nine additional febrile seizures attributable to DTP vaccine for every 100,000 children who are vaccinated and 25 to 34 additional febrile seizures attributable to MMR vaccine,” the investigators say.

A follow-up analysis showed that children who had had febrile seizures after being given either vaccine were at no greater risk of epilepsy or of developing learning, behavioural or psychiatric disorders than children who had suffered febrile seizures but had not been vaccinated. There was no significant increase in febrile or non-febrile seizures at any other time after injection of either vaccine.

“A transient increase in the risk of febrile seizures should not obscure the benefits of vaccination with the DTP and MMR vaccines...Vaccination with DTP and MMR vaccines has also reduced the incidence of neurological disabilities that would have resulted from pertussis or measles,” the investigators conclude (New England Journal of Medicine 2001;345:656).

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal